As reported by the New York Times today. The DREAM study, which Glaxo, the manufacturer of Avandia ran to prove that Avandia would improve the health of people without diabetes so they could sell it to everyone else, instead found this:"...patients taking Avandia had 66 percent more heart attacks, 39 percent more strokes and 20 percent more deaths from cardiovascular-related problems. That
